LLY

A Nice Prop for Stocks in 2013: Buybacks

Like 'em or not, repurchases will at least keep a floor under stocks. And lots of big companies still have billions of dollars in authorizations laying fallow. More 

Sector Scan: Medical Stocks

This week medical stocks like Merck and Pfizer are looking healthy enough to buy or play calls on More 

Effective Alzheimer’s Drugs May Be Just Three Years Away

New research, both by scientists and the big drug companies, is leading to increased hope for sufferers of Alzheimer's disease. More 

Sector Scan: Medical Stocks

These medical stocks were in downward trends, but are rising temporarily before they hit resistance – which means opportunity for calls More 

Biotech Movers: Regeneron Pops, 3 Flop

While Regeneron soared on behind its macular degeneration treatment, Dynavax, Navidea and AspenBio suffered serious setbacks. More 

Buy This Healthcare Stock & Avoid the Sickly Picks

My Power Options system identifies the most volatile and liquid stocks for option trading or short-term stock trading, and this week it’s showing overall weakness in the hospital supply, management and pharmaceutical areas. More 

What Will Happen To Dividend Taxes Under Obama?

Yesterday, I offered some of my immediate reactions to the election as well as my outlook for Wall Street under President Obama and today its about dividends More